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Monoclonal antibodies were obtained after fusion of mouse myeloma cells with spleen cells isolated from mice
primed with a crude extract of yeast killer toxin produced by a strain of Hansenula anomala. Hybridomas were
selected by specific immunoassay reaction of their fluid with crude yeast killer toxin extract. Among the
monoclonal antibodies, which were characterized by the Western blot technique, one (designated KT4) proved
to have precipitating properties, thus permitting the neutralization of the killer activity of the toxin.
Experiments in double immunodiffusion showed that monoclonal antibody KT4 produced homologous
precipitin bands by reacting with either the crude toxin used as immunogen or a toxic extract of Hansenula
mrakii. It is suggested that these monoclonal antibodies will be useful for the purification, characterization, and
understanding of the bioactions of yeast killer toxins.
Previous studies have shown that killer yeasts and their
toxins might be effectively used to differentiate strains of
opportunistic yeasts for epidemiological purposes (3, 4, 6).
Later, we observed that the killer phenomenon, which was
previously considered to be restricted to yeasts, was also
displayed by killer yeasts against unrelated microorganisms
(bacteria, hyphomycetes, lipophilic yeasts, aerobic actinomy-
cetes, and achlorophyllous microorganisms) (9). The diverse
biological activity of killer yeasts and the potential therapeu-
tic effect shown by a crude toxic extract of Hansenula
anomala topically applied to laboratory animals experimen-
tally infected with Malassezia furfur and Malassezia
pachydermatis (L. Polonelli, R. Lorenzini, F. De Bernardis,
and G. Morace, Mycopathologia, Myco 172) prompted us to
try to isolate and purify yeast killer toxins. Since conven-
tional chemical procedures (gel-exclusion chromatography,
chromatofocusing, and anion-exchange chromatography)
proved to be unsuitable for the large-scale production of
purified killer toxin, monoclonal antibodies were produced
for the immunochemical purification (affinity chromatogra-
phy) of yeast killer toxins.
In this study, we report the production and characteriza-
tion of two monoclonal antibodies against a killer toxin
produced by H. anomala.
Cultures. The yeast isolate used for the production of
killer toxin, H. anomala UCSC 25F, was from our collec-
tion. The selection was made on the basis of its broad range
of activity against unrelated microorganisms (9) and the
demonstration of a potential therapeutic effect (Polonelli et al.,
Myco 172). Hansenula mrakii UCSC 255 and Candida
albicans UCSC 10 were also from our culture collection.
Production of crude killer toxin (reference antigen). The
production of crude killer toxin for mouse immunization was
carried out as described elsewhere (6). Flasks (1-liter vol-
ume) with 500 ml of Sabouraud broth, buffered at pH 3 with
0.1 M citric acid and 0.2 M K2HPO4, were seeded with a
loopful of a 48-h-old culture of H. anomala UCSC 25F and
incubated at 220C for 18 h at 70 rpm on a gyratory shaker.
After this period, the cells were removed by centrifugation at
1,500 x g at 40C, and the supernatant was filtered and
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concentrated with a PM-10 membrane in a TCF1OA ultrafil-
tration cell under N2 pressure (Amicon Corp., Danvers,
Mass.). The protein and polysaccharide concentrations in
the concentrated (x50) product were 6 and 2 mg/ml, respec-
tively, as determined by the Lowry method and anthrone
test. Accordingly, a concentrated (x50) extract of the
growth medium (Sabouraud broth, modified; Difco Labora-
tories, Detroit, Mich.) was prepared.
Mouse immunization. H. anomala UCSC 25F concen-
trated (x50) crude toxic extract was the antigen used for
mouse immunization. Four BALB/c mice were injected
according to the schedule previously used for mouse immu-
nization with C. albicans soluble antigen (8). Briefly, 0.1 ml
of the reference antigen was mixed with 0.1 ml of incomplete
Freund adjuvant and injected into each mouse intraperito-
neally once a week for 1 month. Three days before the
fusion, a booster injection was given intraperitoneally with
0.1 ml of the reference antigen alone.
Production and screening of hybridomas. Hybridization
was performed according to the procedures previously de-
scribed (7). Three days after the booster injection, the mice
were sacrificed, and their spleens were removed. The spleen
cells were fused with an equal number ofNS1 myeloma cells
by using polyethylene glycol 1000. The cell culture was
subjected to a 1-month-long selection regime which included
adding hypoxanthine, aminopterin, and thymidine to the
culture medium. To screen for the hybrids producing the
desired antibody, the hybrid fluids were comparatively
tested by enzyme-linked immunosorbent assay (10) in either
Nunc microtitration plates (GIBCO Laboratories, Grand
Island, N.Y.) coated with the reference antigen (concen-
trated [xSO] crude toxic extract of H. anomnala UCSC 25F
diluted 1:1,000 in carbonate buffer [pH 9.6]) or microtitration
plates coated with equally diluted growth medium extract.
Hybridoma cultures secreting antibodies reacting only with
the reference antigen were propagated and cloned twice by
limiting dilution in the presence of mouse thymocytes.
Clones continuing to produce the antibody were expanded.
The monoclonality and immunoglobulin class of the antibod-
ies produced were ascertained by testing them by immuno-
diffusion against rabbit anti-mouse immunoglobulin (Miles
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FIG. 1. Western blot analysis of killer toxin monoclonal antibod-
ies. Their molecular masses are expressed in kilodaltons.
Western blot analysis. Sodium dodecyl sulfate-10% poly-
acrylamide gel electrophoresis of the crude killer toxin and
its subsequent transfer for detecting monoclonal antibodies
against polypeptides transferred to nitrocellulose were car-
ried out as previously reported (5). Electrophoresis was
performed at 15 mA for 18 h, and then the proteins were
electrically transferred to nitrocellulose sheets at 60 V for 3
h. The nitrocellulose sheets were cut into strips and incu-
bated at room temperature with 5% horse serum for 30 min
in phosphate-buffered saline (pH 7.6). Subsequently, the
strips were incubated at 37°C with 2 ml of a 1:10 dilution of
hybridoma culture fluid in a gyratory shaker for 30 min. They
were successively washed for 10 min with phosphate-
buffered saline, blocked with 5% horse serum in phosphate-
buffered saline, and incubated for 30 min at 37°C in a shaker
with 3 ml of horseradish peroxidase-coupled rabbit anti-
mouse immunoglobulin G (IgG). After being washed for 30
min with two changes of phosphate-buffered saline, the
strips were stained with 4-chloro-1-naphthol and hydrogen
peroxide.
Production of ascites fluids and immunodiffusion proce-
dures. The production of ascites fluids for obtaining concen-
trated immunoglobulin and the immunodiffusion procedure
for detecting the precipitating properties of ascites fluids
with killer toxins were performed according to procedures
reported elsewhere (G. Morace, G. Amalfitano, and L.
Polonelli, Mycopathologia, in press). Hybridoma cells (107)
were injected intraperitoneally into pristane-treated syn-
geneic mice. The precipitating properties of the ascites fluid
were ascertained by an agar-gel double immunodiffusion
technique with the reference antigen.
Neutralization of killer toxin. Neutralization of the toxic
activity of the killer toxin was carried out by adding gradu-
ated amounts of precipitating monoclonal antibody ascites
fluid to 1 ml of crude killer toxin. The neutralizing properties
of the precipitating monoclonal antibody were ascertained
after 24 h at 4°C by discarding the sediment and testing the
supernatants (restored to the initial volume with a Minicon
B15 concentrator [Amicon Corp.]) for toxic activity against
a recognized sensitive strain of C. albicans, UCSC 10.
Control tests were carried out by using ascites fluid contain-
ing a nonspecific monoclonal antibody.
Three thousand hybridomas were obtained from the fusion
of NS1 myeloma cells with spleen cells from the four mice
immunized with the crude toxic extract of H. anomala
UCSC 25F. Comparative enzyme-linked immunosorbent
assay, used for selecting the antibody-producing hybrids,
was used to determine the reactivity of the antibodies in the
culture fluid. The hybrids that produced antibodies which
reacted with the antigen constituted by the growth medium
were discarded. The hybrids that produced antibodies which
reacted only with the reference antigen were expanded and
cloned. Ten clones were obtained, and monoclonal antibod-
ies of the IgG class were produced. When the H. anomala
UCSC 25F reference antigen was electrophoretically sepa-
rated in denaturing gels and then immobilized on nitrocellu-
lose strips, we detected only slight diversity among the
monoclonal antibodies to the killer toxin proteins. One type
of monoclonal antibody (designated KT1) showed a greater
avidity than the other (designated KT4), although both of
them reacted with the antigenic determinants that had mo-
lecular masses of 92 and 115 kilodaltons (Fig. 1).
Antibody-rich ascitic fluids produced from both of the
expanded clones reacted differently in immunodiffusion tests
with the homologous reference antigen. Monoclonal anti-
body KT4 produced a clear precipitin band, whereas mono-
clonal antibody KT1 failed to precipitate with the antigen.
FIG. 2. Double immunodiffusion of killer toxin monoclonal anti-
body KT4. Well contents: C, KT4 monoclonal antibody; 1 and 4, H.
anomala UCSC 25F crude killer toxin; 2 and 3, H. mrakii UCSC 255
















FIG. 3. Gradual decrease of activity of yeast killer toxin from H.
anomala UCSC 25F against C. albicans UCSC with 10 with the
addition of graduated amounts of KT4 monoclonal antibody.
Monoclonal antibody KT4 produced homologous precipitin
bands by reacting with the concentrated (x50) crude toxic
extract of a different killer yeast (H. mrakii UCSC 255).
However, it reacted negatively against the equally concen-
trated growth medium extract (Fig. 2).
By adding graduated amounts of KT4-precipitating mono-
clonal antibody (ascitic fluid) to vials containing 1 ml of H.
anomala UCSC 25F crude killer toxin, it was possible to
observe graduated amounts of sediment after 1 night at 4°C
(as the antibody concentration increased, so did that of the
immunoprecipitate). Tests on the toxic activity of the super-
natants, which were restored to their original volume,
against the sensitive strain of C. albicans, UCSC 10, showed
a gradual decrease in and finally the neutralization of the
killer toxin activity (Fig. 3). No neutralization was observed
by adding equal amounts of a nonspecific monoclonal anti-
body (ascites fluid) used as a control.
Killer toxins have proven to be metabolic products of
great interest since the time that the killer phenomenon was
discovered in yeasts (1). Numerous studies have been
done on the molecular biology of the yeast killer factor, the
detection of double-stranded RNA viruslike particles (retro-
viruses), the mechanism of action, and the involvement of
nuclear genes, making the killer toxin system an interesting
system for various investigations. Partial purification of
yeast kiler toxins has revealed that they are glycoproteins (2).
The production of monoclonal antibodies to the killer
toxin of a representative killer yeast (H. anomala UCSC
25F) might effectively contribute to the immunochemical
purification of killer toxins by affinity chromatography and
the characterization (gel filtration) and understanding of their
binding and localization by immunocolloidal gold electron
microscopy.
The precipitating properties of monoclonal antibody KT4
made possible the neutralization of the killer activity of a
crude killer toxin extract, thus demonstrating that monoclo-
nal antibody KT4 was directed against an antigenic determi-
nant of the yeast killer toxin and not against some of the
other metabolites produced in the growth medium.
Double immunodiffusion experiments allowed us to deter-
mine that monoclonal antibody KT4 was reacting with an
antigenic determinant shared by at least one other killer
toxin strain (H. mrakii UCSC 255). The serologic analysis of
numerous yeast killer toxins with monoclonal antibodies by
either the Western blot technique or double immunodiffusion
is now in progress in our institute.
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